Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
Authors:
- 15 September 2021
- journal article
- research article
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 175,p. e63097
Abstract
The ability to study human cardiac development in health and disease is highly limited by the capacity to model the complexity of the human heart in vitro. Developing more efficient organ-like platforms that can model complex in vivo phenotypes, such as organoids and organs-on-a-chip, will enhance the ability to study human heart development and disease. This paper describes a protocol to generate highly complex human heart organoids (hHOs) by self-organization using human pluripotent stem cells and stepwise developmental pathway activation using small molecule inhibitors. Embryoid bodies (EBs) are generated in a 96-well plate with round-bottom, ultra-low attachment wells, facilitating suspension culture of individualized constructs. The EBs undergo differentiation into hHOs by a three-step Wnt signaling modulation strategy, which involves an initial Wnt pathway activation to induce cardiac mesoderm fate, a second step of Wnt inhibition to create definitive cardiac lineages, and a third Wnt activation step to induce proepicardial organ tissues. These steps, carried out in a 96-well format, are highly efficient, reproducible, and produce large amounts of organoids per run. Analysis by immunofluorescence imaging from day 3 to day 11 of differentiation reveals first and second heart field specifications and highly complex tissues inside hHOs at day 15, including myocardial tissue with regions of atrial and ventricular cardiomyocytes, as well as internal chambers lined with endocardial tissue. The organoids also exhibit an intricate vascular network throughout the structure and an external lining of epicardial tissue. From a functional standpoint, hHOs beat robustly and present normal calcium activity as determined by Fluo-4 live imaging. Overall, this protocol constitutes a solid platform for in vitro studies in human organ-like cardiac tissues.Keywords
This publication has 35 references indexed in Scilit:
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicityNature Medicine, 2016
- Revisiting Cardiac Cellular CompositionCirculation Research, 2016
- In vitro generation of human pluripotent stem cell derived lung organoidseLife, 2015
- Cerebral organoids model human brain development and microcephalyNature, 2013
- Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of CardiotoxicityCirculation, 2013
- Genetics of Congenital Heart DiseaseCirculation Research, 2013
- Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signalingProceedings of the National Academy of Sciences of the United States of America, 2012
- Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated CardiomyopathyScience Translational Medicine, 2012
- Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct ReprogrammingCell Stem Cell, 2012
- Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytesStem Cell Research, 2010